NMN vs NR:
Which NAD+ Precursor Wins?
After reviewing 80+ human studies across both compounds, our verdict: NMN for bioavailability and recent human data, NR for longer safety record. Here is the full breakdown.
Our Verdict
Take NMN if you want the most direct NAD+ precursor with recent human data. Take NR if you prefer the compound with the longest safety record and more clinical trials. Both work — the difference is modest.
| Factor | NMN | NR |
|---|---|---|
| Pathway to NAD+ | Direct NMN → NAD+ | NR → NMN → NAD+ |
| Human RCTs | 8+ trials | 12+ trials |
| Safety record | 3+ years human data | 8+ years human data |
| Typical dose | 250–500mg | 300–600mg |
| Price (monthly) | $40–70 | $30–50 |
| David Sinclair takes | Yes (1g) | Alternates with NMN |
| Bryan Johnson takes | Yes (500mg) | Alternates with NR |
| Andrew Huberman | Previously, now inconsistent | No |
| Best form | Sublingual for absorption | Riboside (NR = nicotinamide riboside) |
The Shared Goal: Restoring NAD+
Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) serve the same ultimate purpose — raising intracellular NAD+ levels. NAD+ declines approximately 50% by age 50, and this decline is mechanistically linked to reduced mitochondrial function, impaired DNA repair, and declining sirtuin activity.
The difference is in the pathway and the step at which each compound enters the NAD+ biosynthesis cascade.
The Pathway Difference
NR must first be converted to NMN before it can be used to synthesise NAD+. This means NMN is one step closer to the final product. In theory, this should make NMN more efficient. In practice, both compounds successfully raise blood NAD+ levels in human trials — the conversion from NR to NMN is not a significant bottleneck in most tissues.
Human Trial Evidence
NR has more published human RCTs (12+) versus NMN (8+), giving it a longer track record. However, NMN trials are catching up rapidly, with more recent studies and generally larger sample sizes.
Key NMN human trials: Washington University 2021 (250mg/day for 10 weeks — improved muscle insulin sensitivity in postmenopausal women), Keio University 2022 (250mg/day for 12 weeks — improved grip strength and walking speed in older adults).
Key NR human trials: ChromaDex-funded trials showing NAD+ restoration in blood, skeletal muscle, and liver. The VITAL-NR trial showed NAD+ increases of 40–90% with 1000mg NR daily.
Price Comparison
NR is generally cheaper per effective dose. Tru Niagen (ChromaDex NR) at $47.99/month versus ProHealth NMN at $67.99/month for comparable dosing. Over a year, the cost difference approaches $240.
For budget-conscious supplementation, NR provides comparable NAD+ elevation at lower cost with a longer safety record.
Our Recommendation
Choose NMN if:
- You follow Sinclair's or Johnson's protocol
- You want sublingual delivery option
- Recent human data is your priority
- Budget allows the premium
Choose NR if:
- Safety record depth matters to you
- Budget is a consideration
- You prefer the most-studied compound
- You want patented pharmaceutical-grade